Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 93
- 试验地点
- 2
- 主要终点
- Aerobic fitness
研究概览
简要总结
The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.
详细描述
This will be a randomized, non-blinded prospective intervention testing the effects of two types of exercise training, whole body and isolated single leg, on HFpEF patients with either central or peripheral limitations to exercise training. Subjects will undergo baseline maximal exercise testing and invasive right heart catheterization to define exercise tolerance and pulmonary and cardiac pressures during exercise. Based on the results of baseline testing, subjects will be divided into either centrally limited, defined as excessive rise in pulmonary capillary wedge pressure more than 25 mmHg that decreases after administration of sub-lingual nitroglycerin resulting in improved exercise tolerance, or peripherally limited, defined as no improvement in exercise tolerance despite reduction in pulmonary capillary wedge pressure after sublingual nitroglycerin. After baseline testing, subjects will be randomized to either whole body cycle exercise supplemented with sublingual nitroglycerin to improve training responsiveness or isolated single leg exercise training for 4 months. After 4 months, subjects will repeat maximal exercise testing and invasive right heart catheterization to assess responses to 4 months of exercise training.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 60 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •signs and symptoms of heart failure
- •an ejection fraction > 0.50
- •objective evidence of diastolic dysfunction
排除标准
- •age < 60 years
- •BMI > 50 kg/m2
- •PDE5 inhibitor use
- •Severe valvular disease
- •Severe COPD
- •CKD 4 or higher
- •Contra-indication to MRI.
研究组 & 干预措施
Central HFpEF whole body exercise
HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to whole body cycle training.
干预措施: Exercise training (Behavioral)
Central HFpEF isolated single leg exercise
HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to isolated single leg training.
干预措施: Exercise training (Behavioral)
Peripheral HFpEF whole body exercise
HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to whole body cycle training.
干预措施: Exercise training (Behavioral)
Peripheral HFpEF isolated single leg exercise
HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to isolated single leg training.
干预措施: Exercise training (Behavioral)
结局指标
主要结局
Aerobic fitness
时间窗: 4 months
Change in peak VO2 after exercise training
次要结局
- Sympathetic activity(4 months)
- Cardiac fibrosis(4 months)
- Cardiopulmonary hemodynamics(4 months)
- Leg blood flow(4 months)
研究者
Benjamin Levine
Professor
University of Texas Southwestern Medical Center
